Related Experiment Video

Updated: Dec 10, 2025

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.3K

A review of the Surgical Treatment for Ischemic Heart Failure trial

Imran Khan1

  • 1Department of Cardiothoracic Surgery, Al Mana General Hospital, Al Khobar, Saudi Arabia.

Asian Cardiovascular & Thoracic Annals
|September 2, 2020
PubMed

Insights

Optimal treatment for ischemic heart disease with severe left ventricular dysfunction remains debated. The Surgical Treatment for Ischemic Heart Failure trial

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Optimal management for ischemic heart disease with severe left ventricular dysfunction is unclear.
  • The Surgical Treatment for Ischemic Heart Failure (STICH) trial is a key study in this area.
  • Recent 10-year follow-up data from STICH subsets are now available.

Purpose of the Study:

  • To review clinical issues related to the STICH trial and its sub-studies.
  • To assess the relevance of STICH findings in current clinical practice.
  • To provide insights into the treatment of ischemic cardiomyopathy.

Main Methods:

  • Review of published 10-year follow-up data from the STICH trial.
  • Analysis of various subsets and clinical issues within the trial.
  • Synthesis of findings for application in modern clinical settings.

Main Results:

  • The STICH trial compared coronary artery bypass grafting plus optimal medical therapy versus coronary artery bypass grafting plus surgical ventricular restoration.
  • 10-year follow-up data provide long-term insights into patient outcomes.
  • Sub-study analyses offer nuanced understanding of treatment effects.

Conclusions:

  • The review synthesizes critical clinical issues from the STICH trial.
  • Findings are evaluated for their applicability to contemporary patient care.
  • This analysis aids in decision-making for ischemic heart failure management.

Keywords:
Cardiovascular agentscoronary artery bypassheart failureheart ventriclesmyocardial ischemiarandomized controlled trials as topic.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.8K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
125
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
151
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
182
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
222
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
149
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
187